Drugs / Spironolacton
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00843388 Comparator | Mar 2009 → Mar 2010 | diabetic kidney disease, type 1 diabetes mellitus | Steno Diabetes Center Copenhagen | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Spironolacton | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00843388 ↗ |
| Known as | hexalacton(R) | “Spironolacton (hexalacton(R))” NCT00843388 ↗ |